| Literature DB >> 34332598 |
Cheng Shen1, Hu Liao2.
Abstract
BACKGROUND: There were very few reports of Rosai-Dorfman disease in the thymus, which known as sinus histiocytosis with massive lymphadenopathy. It usually accompanied with other systemic symptoms such as fever, malaise, night sweats, or weight loss in the short term. Case presentation We herein report a rare case of RDD of thymic origin and a review of the literature concerning the clinical and pathological features of this disease, which is often misdiagnosed as thymoma. The patient was underwent thymectomy to extirpate the lesion completely by video-assisted thoracic surgery.Entities:
Keywords: Prognosis; Rosai–Dorfman disease; Surgery; Thymus
Year: 2021 PMID: 34332598 PMCID: PMC8325809 DOI: 10.1186/s13019-021-01595-8
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1Chest contrast-enhanced CT and histological features and of the case. a and b: Contrast-enhanced CT scan showing partial enhancement in soft tissue, measuring 1.7 cm × 1.5 cm in size, in the anterior mediastinum
Fig. 2Histological features. Hematoxylin and eosin (H&E) indicated a cross distribution of deeply and lightly stained lesions. The deeply stained zone was mainly composed of a large number of plasma cells and lymphocytes, and interspersed in a flake-like, lightly stained area like stripes. The giant pleomorphic tissue cells characterized by abundant cytoplasm, vacuoles, large nuclei, and irregular nucleus were distributed in the lightly stained area. In the cytoplasm of histiocytes, emperipolesis showed as some lymphocytes and a small number of plasma cells were phagocytized
Fig. 3Immunohistochemistry results. S‑100 protein staining was strong positive. Thymus-associated epithelial cell indicators CK19 and P63 were positive. Cyclin D1, OCT-2, CD20, CD79a, SMA, CD30, CD10 and CD3 were also positive, and Ki67 index was about 5% in lymphocytes and plasma cells. (a Ki67, b S‑100 protein, c CK19, d P63, e Cyclin D1, f OCT-2, g CD20, h CD79a, i SMA, j CD30, k CD10, l CD3)